United States (US) Infectious Disease Rapid Diagnostic Testing Market (2026-2032) Outlook | Trends, Revenue, Companies, Growth, Industry, Forecast, Size, Analysis, Share & Value
Market Forecast By Product (Assays, Kits and Reagents, Instruments, Services and Software), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing and NGS, Other Technologies), By End-users (Physician Offices, Reference Laboratories, Hospitals, Academic and Research Institutes, Others) And Competitive Landscape
| Product Code: ETC071540 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
United States (US) Infectious Disease Rapid Diagnostic Testing Market Size, Share & Growth Rate
The United States (US) Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 166 Million in 2025 and is projected to reach USD 196 Million by 2032, growing at a CAGR of 2.4% from 2026 to 2032. This growth trajectory is primarily driven by the increasing prevalence of infectious diseases, particularly in the wake of public health emergencies such as the COVID-19 pandemic. The urgent need for quick and accurate diagnostic solutions is further influencing healthcare providers to adopt rapid testing methods, enhancing the overall efficiency of patient management and treatment.
United States (US) Infectious Disease Rapid Diagnostic Testing Market Year-wise Growth Rate and Key Drivers
This graph highlights how the United States (US) Infectious Disease Rapid Diagnostic Testing Market has steadily grown over the years, supported by major growth factors.
The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -0.3% | Rising electricity demand across industries |
| 2022 | 6.3% | Expansion of manufacturing activities |
| 2023 | 3.1% | Increasing industrial automation investments |
| 2024 | 2.9% | Expansion of commercial construction activities |
| 2025 | 2.9% | Rising electricity demand across industries |
| 2026 | 2.7% | Increasing adoption of advanced technologies |
| 2027 | 2.9% | Expansion of commercial construction activities |
| 2028 | 3.0% | Increasing industrial infrastructure investments |
| 2029 | 2.5% | Growing urbanization and commercial development |
| 2030 | 2.9% | Increasing adoption of advanced technologies |
| 2031 | 2.7% | Increasing smart city development projects |
| 2032 | 2.4% | Increasing adoption of advanced technologies |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
United States (US) Infectious Disease Rapid Diagnostic Testing Market Synopsis
The strongest force currently shaping the US Infectious Disease Rapid Diagnostic Testing Market is the rising demand for point-of-care testing. This paradigm shift towards decentralized diagnostic solutions enables healthcare professionals to make immediate treatment decisions, which is critical in managing infectious disease outbreaks effectively.
Another key factor influencing market dynamics is the technological advancements in diagnostic testing. The continuous evolution of testing technologies, including multiplex testing platforms, has expanded the range of detectable pathogens, further propelling market growth as healthcare systems seek comprehensive diagnostic capabilities.
United States (US) Infectious Disease Rapid Diagnostic Testing Market Key Takeaways
- The market is witnessing significant growth driven by the urgent need for rapid testing solutions and the rising prevalence of infectious diseases.
- Point-of-care testing is becoming increasingly popular due to its ability to provide immediate results, facilitating timely clinical decisions.
- Innovative technologies and the expansion of test menus are crucial factors for maintaining competitiveness in the market.
- Government initiatives aimed at improving testing accessibility and affordability are expected to enhance market opportunities.
- Investment in research and development is critical for introducing advanced and user-friendly diagnostic solutions.
Evaluation of Restraints in United States (US) Infectious Disease Rapid Diagnostic Testing Market
Despite the promising growth, the US Infectious Disease Rapid Diagnostic Testing Market faces notable restraints. One prominent issue is the need for ongoing technological advancements to ensure tests remain both accurate and efficient. Additionally, the lengthy approval process mandated by the FDA can delay the introduction of innovative testing solutions. Furthermore, intense competition among market players creates pricing pressures and challenges in differentiating product offerings, complicating the market landscape.
United States (US) Infectious Disease Rapid Diagnostic Testing Market Trends
Current trends in the market are marked by a strong push towards integration with telemedicine and remote healthcare settings. As healthcare systems adapt to evolving patient needs, the incorporation of rapid diagnostic testing into digital platforms facilitates improved access to healthcare. Furthermore, the popularity of multiplex testing platforms continues to rise, enabling the simultaneous detection of multiple pathogens and aligning with the demand for comprehensive diagnostic solutions.
United States (US) Infectious Disease Rapid Diagnostic Testing Market Opportunities
The market presents substantial investment opportunities, particularly in the realm of point-of-care testing solutions. Companies that focus on developing innovative testing kits and digital platforms for result interpretation are poised for growth. Additionally, the trend toward public health preparedness, along with an increasing acceptance of at-home testing solutions, indicates a fertile landscape for strategic partnerships and marketing initiatives aimed at enhancing product penetration.
Government Initiatives in the United States (US) Infectious Disease Rapid Diagnostic Testing Market
Government policies play a pivotal role in shaping the landscape of the Infectious Disease Rapid Diagnostic Testing Market. The FDA's regulations ensure that diagnostic tests meet rigorous standards of accuracy and reliability. Additionally, reimbursement policies set by the Centers for Medicare and Medicaid Services (CMS) impact the adoption and utilization of these tests. During public health emergencies, federal funding and grants are typically allocated to bolster research and development, ultimately enhancing accessibility to rapid diagnostic testing solutions.
Future Insights of the United States (US) Infectious Disease Rapid Diagnostic Testing Market
Looking ahead to 2026-2032, the US Infectious Disease Rapid Diagnostic Testing Market is positioned for substantial expansion. Increasing awareness of the importance of early detection and the ongoing development of innovative rapid testing technologies will fuel market growth. The demand for point-of-care testing solutions is expected to rise, thanks to their ability to provide rapid and accurate results that support timely treatment decisions. As healthcare systems prioritize innovative diagnostics to combat infectious disease outbreaks, investments in user-friendly technologies will likely gain traction, resulting in improved patient outcomes.
United States (US) Infectious Disease Rapid Diagnostic Testing Market Latest Developments (May 2025 - June 2026)
Recent industry developments indicate a notable shift towards advanced rapid testing methodologies, driven by ongoing public health concerns. Companies are increasingly focusing on enhancing the sensitivity and specificity of their testing solutions to ensure reliability. Additionally, partnerships with telehealth providers are emerging as a strategy to integrate rapid diagnostic capabilities into remote healthcare solutions, ensuring greater accessibility for patients.
United States (US) Infectious Disease Rapid Diagnostic Testing Market - Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year: 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- United States (US) Infectious Disease Rapid Diagnostic Testing Market Outlook
- Market Size of United States (US) Infectious Disease Rapid Diagnostic Testing Market, 2025
- Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market, 2032
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Revenues & Volume for the Period 2022-2032F
- United States (US) Infectious Disease Rapid Diagnostic Testing Market Trend Evolution
- United States (US) Infectious Disease Rapid Diagnostic Testing Market Drivers and Challenges
- United States (US) Infectious Disease Rapid Diagnostic Testing Price Trends
- United States (US) Infectious Disease Rapid Diagnostic Testing Porter's Five Forces
- United States (US) Infectious Disease Rapid Diagnostic Testing Industry Life Cycle
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Product for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Assays, Kits and Reagents for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Instruments for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Services and Software for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Technology for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Immunodiagnostics for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Clinical Microbiology for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By PCR for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By INAAT for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By DNA Sequencing and NGS for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Other Technologies for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By End-users for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Physician Offices for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Reference Laboratories for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Hospitals for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Academic and Research Institutes for the Period 2022-2032F
- Historical Data and Forecast of United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume By Others for the Period 2022-2032F
- United States (US) Infectious Disease Rapid Diagnostic Testing Import Export Trade Statistics
- Market Opportunity Assessment By Product
- Market Opportunity Assessment By Technology
- Market Opportunity Assessment By End-users
- United States (US) Infectious Disease Rapid Diagnostic Testing Top Companies Market Share
- United States (US) Infectious Disease Rapid Diagnostic Testing Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Infectious Disease Rapid Diagnostic Testing Company Profiles
- United States (US) Infectious Disease Rapid Diagnostic Testing Key Strategic Recommendations
United States (US) Infectious Disease Rapid Diagnostic Testing Market - Frequently Asked Questions
The market is primarily driven by the increasing prevalence of infectious diseases, the urgent need for rapid diagnostics in clinical settings, and advancements in testing technologies that enhance accuracy and user-friendliness.
The United States Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 166 Million in 2025 and is projected to reach USD 196 Million by 2032, growing at a CAGR of 2.4% from 2026 to 2032.
Key technological trends include the rise of multiplex testing platforms, which allow for the detection of multiple pathogens simultaneously, and the integration of rapid testing into telemedicine, enhancing patient access to diagnostics.
Government regulations, particularly those enforced by the FDA, ensure that diagnostic tests meet safety and efficacy standards. Additionally, reimbursement policies from CMS can significantly impact the market by facilitating wider adoption of rapid testing solutions.
Companies are encouraged to invest in point-of-care testing solutions, innovative digital platforms for result interpretation, and research and development aimed at creating more advanced testing technologies that can cater to the evolving needs of healthcare providers.
6Wresearch actively monitors the United States (US) Infectious Disease Rapid Diagnostic Testing Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Infectious Disease Rapid Diagnostic Testing Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 United States (US) Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.6 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 United States (US) Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the United States |
4.2.2 Growing awareness about the importance of early disease detection and treatment |
4.2.3 Technological advancements leading to the development of more accurate and faster diagnostic tests |
4.3 Market Restraints |
4.3.1 Stringent regulations and approvals required for diagnostic tests |
4.3.2 High cost associated with rapid diagnostic testing kits |
4.3.3 Limited access to healthcare facilities in certain regions of the United States |
5 United States (US) Infectious Disease Rapid Diagnostic Testing Market Trends |
6 United States (US) Infectious Disease Rapid Diagnostic Testing Market, By Types |
6.1 United States (US) Infectious Disease Rapid Diagnostic Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 United States (US) Infectious Disease Rapid Diagnostic Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Others, 2022-2032F |
7 United States (US) Infectious Disease Rapid Diagnostic Testing Market Import-Export Trade Statistics |
7.1 United States (US) Infectious Disease Rapid Diagnostic Testing Market Export to Major Countries |
7.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market Imports from Major Countries |
8 United States (US) Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Adoption rate of rapid diagnostic testing by healthcare facilities |
8.3 Number of partnerships and collaborations between diagnostic test manufacturers and healthcare providers |
8.4 Percentage increase in the use of rapid diagnostic tests for infectious diseases over time |
9 United States (US) Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
9.1 United States (US) Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 United States (US) Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 United States (US) Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
10.1 United States (US) Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Global Go To Market Strategy - 2030
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here
Pricing
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Leadership Perspectives from Industry Events
Search
Thought Leadership and Analyst Meet
Our Clients
6WResearch In News
- India Air Conditioner Market Set for Strong Rebound in 2026 After Weather-Led Correction and GST-Driven Recovery: 6Wresearch
- ADAS in India: How Automatic Emergency Braking, Blind Spot Detection & Driver Monitoring are Transforming Road Safety
- Doha a strategic location for EV manufacturing hub: IPA Qatar
- Demand for luxury TVs surging in the GCC, says Samsung
- Empowering Growth: The Thriving Journey of Bangladesh’s Cable Industry
- Demand for luxury TVs surging in the GCC, says Samsung
Latest Reports
- Nicaragua RPG Gaming Market (2026-2032)
- New Zealand RPG Gaming Market (2026-2032)
- Netherlands RPG Gaming Market (2026-2032)
- Nauru RPG Gaming Market (2026-2032)
- Namibia RPG Gaming Market (2026-2032)
- Mozambique RPG Gaming Market (2026-2032)
- Montenegro RPG Gaming Market (2026-2032)
- Mongolia RPG Gaming Market (2026-2032)
- Monaco RPG Gaming Market (2026-2032)
- Micronesia RPG Gaming Market (2026-2032)
Industry Events and Analyst Meet
EV India Expo 2026
HIMTEX 2026
India Refining Summit 2026
India EV Show 2026
EV tech India Expo 2026
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
